Research & Discovery The latest research news in genetics and genomics. Sep 29, 2022 New NIH-Funded Network Aims to Bring Precision to External Beam Radiation Treatment Premium Sep 21, 2022 Propath UK, Nucleai Partner on Spatial Proteomics Panel for Immuno-Oncology Sep 20, 2022 ImmunoScape Raises $14M Sep 1, 2022 Multiple Myeloma Researchers Chip Away at Why Some Patients Relapse Quickly After CAR T-Cell Therapy Premium Jun 28, 2022 Akoya Biosciences, Acrivon Therapeutics Partner to Develop CDx Jun 28, 2022 QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International Jun 13, 2022 OncoHost Licenses SomaLogic Platform to Develop Tests to Predict Patient Response to Immunotherapies Jun 2, 2022 InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma Premium Apr 26, 2022 International LAGENO-BC Consortium Spurring Breast Cancer Genetics Research Across Latin America Premium Apr 21, 2022 Phenome-Wide Association Study Links Hereditary Cancer Genes to Additional Phenotypes Mar 28, 2022 Theralink Using Phosphoproteomics to Guide Treatment in Late-Stage Breast Cancer Premium Mar 22, 2022 InnoSign Raises $8M in Series A Financing, Spins off From Royal Philips Mar 21, 2022 SomaLogic to Process 30K Samples for European Cancer Study Mar 2, 2022 Gene Signature Predicts Response to Chemotherapy, Immunotherapy in Gastric Cancer Premium Feb 24, 2022 Gene Expression Biomarker Panel Shows Prognostic, Predictive Promise for Gastric Cancer Premium Feb 22, 2022 Million Veterans Study Yields Prostate Cancer Risk Score With Promise for Improved Screening Premium Feb 15, 2022 Lantern Pharma Working With Greehey Children's Cancer Research Institute To ID New Uses for Drugs Jan 19, 2022 Protein-Based Liquid Biopsy Panel Assesses Tumor Microenvironment, Shows Prognostic Potential Premium Jan 12, 2022 Grant Funding Supports Research on Kintara's VAL-083 in GBM Models Jan 5, 2022 Aspira Women's Health Preliminary Q4 OVA1 Sales up 23 Percent; Firm Details Pipeline Progess Load More Breaking News Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
